Hepatocellular carcinoma (HCC) is one of the most fatal malignancies. Epigenetic mechanisms have revealed that noncoding RNAs ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...

However, the speed of vaccine production is limited because the mRNA used in it is partly chemically synthesized and partly ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

An mRNA vaccine, a cousin to the COVID vaccines that blunted the pandemic, has entered human trials as a treatment for lung ...

On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $52.8 which represents a decrease of $-0.59 or -1.11% from the prior close of $53.39. The stock opened at $53.39 and touched a ...

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...